An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers
NCT ID: NCT01514019
Last Updated: 2012-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
16 participants
INTERVENTIONAL
2012-01-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean
NCT01445964
Nebivolol in Patients With Systolic Stage 2 Hypertension
NCT01057251
A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants
NCT01902550
The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese
NCT02513927
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
NCT01502787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acebutolol
Acebutolol 200 mg capsule (Acetanol®)
Acebutolol
Acebutolol
Placebo
Placebo
Placebo capsule(Capsules filled up with lactose)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acebutolol
Acebutolol
Placebo
Placebo capsule(Capsules filled up with lactose)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oita University
OTHER
Seoul National University Hospital
OTHER
Kyushu University
OTHER
In-Jin Jang, MD, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In-Jin Jang, MD, PhD
Professor of Clinical Pharmacology and Therapeutics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyoichi Ohashi, MD, PhD
Role: STUDY_CHAIR
Department of Clinical Pharmacology and Therapeutics, Oita University Faculty of Medicine, Oita, Japan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Clinical Research Center, Oita University Hospital
Ōita, , Japan
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012_Acebutolol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.